Follow the ブライトパス・バイオ株式会社 stock price and the full directors' dealings record of the company, a listed issuer based in Japan. Shares are quoted on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, ブライトパス・バイオ株式会社 has logged 31 public disclosures. Market capitalisation: €6.9bn. The latest transaction was filed on 11 July 2025 (Holding update). Among the most active insiders: Evo Fund. All data is openly available.
31
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
9Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,788 of 29,062 companies
26.5
score / 100
Value
11
Quality
42
FCF yld-20%
Earn yld-19%
EV/EBITDA·
ROE-79%
Gross mgn64%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
